OVERVIEW

Examining Real World Evidence in the Management of Breast Cancer: Pharmacist Implications is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians and will be held from Dec 31, 2018 - Dec 31, 2019.

Credits: 2.0 hour (0.2 ceu)

Target Audience:
This accredited activity has been designed for oncology, health system, managed care and specialty pharmacists.

Goal:
To inform oncology, health-system, managed care and specialty pharmacists, as well as other pharmacists who interact with BC patients, on
• real world evidence (RWE) and how it may be used to support approval of new drugs or indications
• approaches to interpreting and analyzing study design and results of real world data (RWD) for possible inclusion in treatment decision making;
• RWE of CDK 4/6 inhibitors in breast cancer for the development of treatment regimens based on patient specific factors thus leading to improved outcomes.

Educational Objectives:
Upon completion of this program, participants should be better able to:
• Recognize real world evidence (RWE) and how it may be used to support approval of new drugs or indications
• Identify approaches to interpreting and analyzing study design and results of real world data (RWD) for possible inclusion in treatment decision making
• Translate RWE of CDK 4/6 inhibitors in breast cancer for the development of treatment regimens based on patient specific factors

Additional details will be posted as soon as they are available.